- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
AVAC puts stakeholder engagement in research into practice.
AVAC is committed to the principle that the perspectives of affected communities belong at the center of research and implementation. In practice, this means bringing together researchers, trial-site staff, civil society groups, people living with HIV, policy makers and many others for constructive, informed dialogue.
We’re making research better through key programs:
Good Participatory Practice (GPP) Guidelines
The GPP guidelines on biomedical HIV prevention research lay the foundation for all this work. The guidelines propose standards and practices for engaging stakeholders in each step of the research process.
Coalition to Accelerate & Support Prevention Research (CASPR)
CASPR, designed by AVAC in collaboration with key partners and supported by USAID, is a set of partnerships and activities supporting the development & sustainability of an Africa-centered network to accelerate biomedical HIV prevention research, toward the goal of HIV epidemic control.
Civil society consultations on research
We prepare civil society to frame concerns and get answers to questions about upcoming trials.
Workshops
We bring program focused on a community perspective to prominent scientific conferences such as CROI and HIV R4P.
Webinars
We conduct global webinars to advance an informed dialogue about landmark trials and hot button issues in the field.
The Vaccine Advocacy Resource Group (VARG)
AVAC supports the work of this global team of HIV prevention research advocates who champion evidenced-based, ethical biomedical solutions to end the epidemic.
What’s Hot in Improving Research Conduct
- Evolving Designs for HIV Prevention Trials
- A Statement on the Future of HIV Prevention Trials
- Designing a New Generation of HIV Prevention Efficacy Trials
- Good Participatory Practice Guidelines for Trials of Emerging (and Re-emerging) Pathogens that are Likely to Cause Severe Outbreaks in the Near Future and for which Few or No Medical Countermeasures Exist
- Good Participatory Practice: Guidelines for TB drug trials
- Stakeholder Input and Recommendations for Good Participatory Practices (GPP) in Biomedical HIV Prevention Trials in Thailand